A biotech known for its sleep and brain drugs just made a $7.2 billion bet that medical cannabis is crucial to its neuroscience ambitions

A biotech known for its sleep and brain drugs just made a $7.2 billion bet that medical cannabis is crucial to its neuroscience ambitions

Jazz Pharmaceuticals is making a $7.2 billion bet on the future of medical cannabis. 
The drugmaker said on Wednesday it will acquire GW Pharma, the maker of CBD-based epilepsy treatment Epidiolex, …
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *